Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics (NYSE: HAE) posted its third quarter fiscal 2026 results for the period ended December 27, 2025, on its Investor Relations website.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics (NYSE: HAE) posted its third quarter fiscal 2026 results for the period ended December 27, 2025, on its Investor Relations website.
The company will host a conference call and live webcast at 8:00 a.m. ET on February 5, 2026, with a replay available from 11:00 a.m. ET on February 5, 2026 for one year. Earnings release and a supplemental presentation are posted and will be referenced on the call.
Details
News Market Reaction – HAE
On Feb 5, the day this news came out, HAE closed 1.41% below the previous close.
Data tracked by StockTitan Argus for the Feb 5 session.
Key Figures
- Quarter end date
- December 27, 2025
- Third quarter fiscal 2026 period end
- Earnings call time
- 8:00 a.m. ET
- Conference call start on February 5, 2026
- Replay start time
- 11:00 a.m. ET
- Replay availability on February 5, 2026
- Replay duration
- 1 year
- Replay accessible via webcast link
Previous Earnings Reports
-
Second quarter FY26 results posted with webcast and replay details.
-
First quarter FY26 financial results posted and discussed via webcast.
-
Fourth quarter and full-year FY25 results with guidance materials released.
-
Third quarter FY25 results made available with investor call and replay.
-
Second quarter FY25 results posted with conference call and webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Financial release and supplemental presentation accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 5, 2026.
Conference Call and Webcast Information:
- Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
- Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on February 5, 2026 and will remain accessible for one year via the webcast link above.
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
- Third Quarter Fiscal 2026 Earnings Release
- Third Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-third-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302679292.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.